Congenital melanocytic nevi: where are we now? Part II. Treatment options and approach to treatment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22980259.
- Also identified by DOI 10.1016/j.jaad.2012.06.022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.
Medical subject headings
- Nevus, Pigmented
- Skin Neoplasms